5th International Conference on Pediatrics and Child Health

Pediatric Endocrinology & Diabetes brings together pediatric endocrinologists, diabetologists, pediatricians, nutritionists, diabetes educators, nurses, researchers, and healthcare professionals to discuss advances in endocrine and metabolic disorders affecting children and adolescents. The session focuses on diabetes, growth and puberty disorders, thyroid and adrenal conditions, childhood obesity, glucose monitoring, artificial pancreas systems, precision medicine, and emerging endocrine therapies.

Key Discussion Areas

• Pediatric Diabetes and Glycemic Management – Type 1 and Type 2 diabetes, insulin therapy, glucose control, and emerging treatment approaches.
• Growth, Puberty and Endocrine Disorders – growth disorders, delayed or early puberty, thyroid, pituitary, and adrenal conditions.
• Childhood Obesity and Metabolic Health – obesity, metabolic syndrome, lifestyle interventions, nutrition, and prevention of long-term complications.
• Diabetes Technology and Precision Endocrinology – continuous glucose monitoring, automated insulin delivery, artificial pancreas systems, genomics, and personalized care.

Benefits of Attending This Session

Pediatric endocrinologists, diabetologists, pediatricians, nurses, nutritionists, diabetes educators, researchers, and healthcare professionals can gain practical insights into modern endocrine and diabetes management. The session provides opportunities to present research, explore emerging diabetes technologies and therapies, discuss complex endocrine disorders, and build collaborations across clinical, research, and healthcare technology communities.

Frequently Asked Questions

Q: Can research on pediatric diabetes technology, obesity, growth disorders, or endocrine diseases be presented in this session?

A: Yes. The session welcomes clinical studies, technology research, metabolic investigations, case studies, therapeutic trials, and translational research related to pediatric endocrinology and diabetes.

Q: Will emerging diabetes technologies and personalized treatment approaches be discussed?

A: Yes. Discussions may include continuous glucose monitoring, automated insulin delivery, artificial pancreas systems, digital diabetes management, genomic medicine, precision nutrition, and emerging endocrine therapies.